![Douglas Sheehy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Sheehy
General Counsel bei
MIRUM PHARMACEUTICALS, INC.
Profil
Douglas T.
Sheehy is Director at Aimmune Therapeutics UK Ltd. since 2017.
Mr. Sheehy will be Chief Legal Officer & Secretary at Mirum Pharmaceuticals, Inc. starting in 2025.
Formerly, Mr. Sheehy was Executive Director-Legal & Corporate Law at CV Therapeutics, Inc. from 2002 to 2007.
Mr. Sheehy was Secretary & Chief Legal Officer at Sonoma Biotherapeutics, Inc. from 2016 to 2020.
Mr. Sheehy served as Secretary, Chief Administrative Officer & EVP at Codexis, Inc. from 2014 to 2016.
Mr. Sheehy worked as Attorney at Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP from 1995 to 2000.
Mr. Sheehy was Attorney at Brobeck, Phleger & Harrison LLP from 1994 to 1995.
Mr. Sheehy was Secretary & General Counsel at Aimmune Therapeutics, Inc. from 2016 to 2020.
Mr. Sheehy earned a graduate degree from American University Washington College of Law in 1994 and an undergraduate degree from Dartmouth College in 1989.
Aktive Positionen von Douglas Sheehy
| Unternehmen | Position | Beginn |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | General Counsel | 19.05.2025 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | 31.03.2017 |
Ehemalige bekannte Positionen von Douglas Sheehy
| Unternehmen | Position | Ende |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | General Counsel | 01.12.2020 |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | General Counsel | 01.01.2020 |
| CODEXIS, INC. | Verwaltungsdirektor | 01.04.2016 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | General Counsel | 01.04.2007 |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
 Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01.08.2000 |
Ausbildung von Douglas Sheehy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Brobeck, Phleger & Harrison LLP
 Brobeck, Phleger & Harrison LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
American University Washington College of Law
 American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sonoma Biotherapeutics, Inc.
Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Wählen Sie MarketScreener 
